Direct treatment-related morbidity and mortality, especially due to infections, cardio-metabolic dysfunction, hepatotoxicity, osteonecrosis and asparaginase-associated problems, such as coagulation disorders and pancreatitis, remain an important issue. The gene discussed is ASPG; the disease is blood coagulation disease.